-
[show abstract]
[hide abstract]
ABSTRACT: The management of dog behavioural problems requires the expertise of professionals such as the veterinary behaviourist. Clinical assessment of behavioural disorders allows the veterinary behaviourist to formulate a diagnosis and prescribe a behavioural and/or pharmacological therapy. The objective of such therapy is to produce a stable change in the perception of a stimulus and the resulting emotion, leading to the correction of the behavioural problem. It may be crucial to evaluate the subject's pathological state in response to the observed symptoms in order to identify the functional impairment of the pivotal neurotransmitter systems involved in the disorder. This allows selecting a suitable pharmacological treatment. In order to implement behavioural therapy, the veterinary behaviourist collaborates, where necessary, with a team of qualified canine trainers.
Annali dell'Istituto superiore di sanita 01/2011; 47(4):378-83. · 0.94 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: A multitude of molecular techniques for monitoring minimal residual disease in lymphoproliferative disorders have been described to date. Real-Time Quantitative PCR targeting Immunoglobulin Heavy chain patient-specific sequences is increasingly being used for molecular detection of residual neoplastic B-cells using allele-specific oligos. The establishment of individually tailored PCR assays with the extensive use of patient-specific fluorescent-labeled oligos may be cumbersome and expensive. The present study was aimed at evaluating the usefulness of recently described hairpin-shaped allele-specific primers, originally intended for typing single-nucleotide polymorphisms, for the assessment of minimal residual disease using SYBR Green intercalating dye. Three cloned and 2 sequenced clonogenic Ig heavy chain rearranged gene loci, obtained from 5 cases of canine spontaneous B-cell lymphoma, were used as an experimental model. Both standard linear and hairpin-shaped forward and reverse clone-specific primers were evaluated in terms of specificity, sensitivity and PCR efficiency. Hairpin-shaped primers were demonstrated to have achieved accurate results more consistently than the respective linear primers allowing the specific and sensitive quantification of minimal residual disease of lymphoproliferative disorders with fewer validation procedures and more flexibility on the assay design.
Molecular and Cellular Probes 08/2009; 24(1):6-14. · 2.08 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Ataxia telangiectasia mutated (ATM) protein is considered a "caretaker" of the genome integrity and a defective ATM has been correlated with increased cancer risk in human beings. In an effort to explore the reliability of dog as a spontaneous animal model of genetic susceptibility to lymphoid malignancies, we have carried out the complete sequencing of the canine ATM mRNA. 5' RACE analysis and sequencing were used to obtain the full-length canine cDNA. The transcription start site was found at CFA5: 27307661 (Dog Genome assembly 2.0, release 49). Two exons were found in the 5'UTR. A putative TATA-less bi-directional promoter region was found in the region 5' upstream of the cap site. The core promoter harbours different conserved regulatory motifs: CREB, CCAAT boxes (NF-binding sites), Sp1, AP-2, GCF, XRE, Ets, Cre and c-Myb. The major ORF, corresponding to the ortholog human and pig ATM isoform 1, has 64 exons and codes a protein of 3056 aa. The homology between dog and human ATM at the aa level was 89% identities-93% positives, even higher than the homology between pig and human. When compared with the canine genomic sequences, 3 sequence variants yielding to aa substitution were found. Canine ATM is highly conserved and may represent a candidate gene to evaluate lymphoid malignancies predisposition in dogs.
Veterinary Immunology and Immunopathology 01/2009; 128(4):437-40. · 2.08 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: To evaluate the effect of passive transfer status, determined by measuring serum IgG concentration 24 hours after parturition, on preweaning growth performance in dairy lambs.
Prospective observational study.
20 healthy Sardinian dairy lambs.
Serum IgG concentration was measured 24 hours after birth. Body weight was measured at birth and at the time of weaning 28 days (ie, 27 to 29 days) after birth. Mean daily gain from birth to day 28 and day 28 weight were used as measures of preweaning growth performance. Regression analysis was used to evaluate associations between serum IgG concentration 24 hours after birth and measures of preweaning growth performance.
Mean +/- SD serum IgG concentration 24 hours after birth was 24.6 +/- 17.5 mg/mL. Mean body weights at birth and weaning were 2,696 +/- 937 g and 9,253 +/- 2,116 g, respectively, and mean daily gain was 234 +/- 63 g/d. No significant association was detected between serum IgG concentration 24 hours after birth and birth weight. However, serum IgG concentration 24 hours after birth was significantly associated with mean daily gain (R(2) = 0.25). Each 1 mg/mL increase in serum IgG concentration 24 hours after birth was associated with a 1.8 g/d increase in mean daily gain and a 60.8-g increase in day 28 weight.
Results indicated that passive transfer status, determined as serum IgG concentration 24 hours after birth, was a significant source of variation in preweaning growth performance in dairy lambs.
Journal of the American Veterinary Medical Association 08/2006; 229(1):111-5. · 1.79 Impact Factor
